(Q37879269)

24 August 2017

1 reference

title

Constructing and deconstructing stem cell models of neurological disease (English)

1 reference

24 August 2017

Constructing and Deconstructing Stem Cell Models of Neurological Disease (English)

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

3 December 2024

3

Kevin C Eggan

1 reference

24 August 2017

Steve S. W. Han

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21609821

3 December 2024

Luis A. Williams

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21609821

3 December 2024

Kevin C. Eggan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21609821

3 December 2024

language of work or name

English

0 references

publication date

1 May 2011

1 reference

24 August 2017

26 May 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21609821

full work available at URL

3 December 2024

http://www.cell.com/article/S0896627311003783/pdf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21609821

https://api.elsevier.com/content/article/PII:S0896627311003783?httpAccept=text/xml

3 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

https://api.elsevier.com/content/article/PII:S0896627311003783?httpAccept=text/plain

3 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

3 December 2024

1 reference

24 August 2017

volume

70

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

626-644

1 reference

Generation of germline-competent induced pluripotent stem cells

24 August 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE05934

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.CELL.2007.11.019

Reprogramming of human somatic cells to pluripotency with defined factors

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE06534

Embryonic stem cell lines derived from human blastocysts

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.282.5391.1145

Human induced pluripotent stem cells free of vector and transgene sequences

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.1172482

Disease-specific induced pluripotent stem cells

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.CELL.2008.07.041

Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.1158799

Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.STEM.2009.05.005

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.STEM.2010.08.012

Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NBT1374

Induced pluripotent stem cell lines derived from human somatic cells

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.1151526

Virus-free induction of pluripotency and subsequent excision of reprogramming factors

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE07864

A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.CELL.2010.10.016

Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.2183/PJAB.85.348

Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.CELL.2009.02.013

Modelling schizophrenia using human induced pluripotent stem cells

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE09915

Somatic coding mutations in human induced pluripotent stem cells

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE09805

Induced pluripotent stem cells from a spinal muscular atrophy patient

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE07677

Generation of human induced pluripotent stem cells from dermal fibroblasts

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1073/PNAS.0711983105

Derivation of Embryonic Stem-Cell Lines from Human Blastocysts

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1056/NEJMSR040330

MeCP2: structure and function

1

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2

3 December 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

3 December 2024

Familial dysautonomia

4

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Adaptation to culture of human embryonic stem cells and oncogenesis in vivo

3 December 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology

3 December 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Lentiviral vectors harboring a dual-gene system allow high and homogeneous transgene expression in selected polyclonal human embryonic stem cells

3 December 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats

3 December 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

The Controlled Generation of Functional Basal Forebrain Cholinergic Neurons from Human Embryonic Stem Cells

3 December 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines

3 December 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

A functionally characterized test set of human induced pluripotent stem cells

3 December 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Staging of brain pathology related to sporadic Parkinson's disease

3 December 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes

3 December 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy

3 December 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?

3 December 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion

3 December 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Identification of small molecules from human embryonic stem cells using metabolomics

3 December 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader–Willi syndromes

3 December 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling

3 December 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Treatment of spinal muscular atrophy by sodium butyrate

3 December 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Optimal timing of inner cell mass isolation increases the efficiency of human embryonic stem cell derivation and allows generation of sibling cell lines

3 December 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation

3 December 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation

3 December 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures

3 December 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells.

3 December 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid.

3 December 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

A method for genetic modification of human embryonic stem cells using electroporation

3 December 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Tissue-specific reduction in splicing efficiency of IKBKAP due to the major mutation associated with familial dysautonomia.

3 December 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Targeting a GFP reporter gene to the MIXL1 locus of human embryonic stem cells identifies human primitive streak-like cells and enables isolation of primitive hematopoietic precursors.

3 December 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Progressive GAA expansions in dorsal root ganglia of Friedreich's ataxia patients.

3 December 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome

3 December 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Sequential genetic modification of the hprt locus in human ESCs combining gene targeting and recombinase-mediated cassette exchange.

3 December 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation

3 December 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Evaluating the utility of cardiomyocytes from human pluripotent stem cells for drug screening.

3 December 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts

3 December 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases

3 December 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Clinical and genetic abnormalities in patients with Friedreich's ataxia

3 December 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Human stem cells and drug screening: opportunities and challenges

3 December 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos

3 December 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals

3 December 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia

3 December 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Mechanisms of neural specification from embryonic stem cells

3 December 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

The ECVAM international validation study on in vitro embryotoxicity tests: results of the definitive phase and evaluation of prediction models. European Centre for the Validation of Alternative Methods

3 December 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Genetic modification of human embryonic stem cells for derivation of target cells

3 December 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Kinetin in familial dysautonomia carriers: implications for a new therapeutic strategy targeting mRNA splicing.

3 December 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Methods for making induced pluripotent stem cells: reprogramming à la carte

3 December 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats

3 December 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Derivation of high-purity oligodendroglial progenitors

3 December 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases

3 December 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency

3 December 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

A mouse model for spinal muscular atrophy

3 December 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Differentiation of spinal motor neurons from pluripotent human stem cells

3 December 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Differentiation of human oligodendrocytes from pluripotent stem cells

3 December 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency

3 December 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds

3 December 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Copy number variation and selection during reprogramming to pluripotency

3 December 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond

3 December 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Identification and targeting of the ROSA26 locus in human embryonic stem cells.

3 December 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

A rapid, generally applicable method to engineer zinc fingers illustrated by targeting the HIV-1 promoter

3 December 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

A scaleable and defined system for generating neural stem cells from human embryonic stem cells.

3 December 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Functional neural development from human embryonic stem cells: accelerated synaptic activity via astrocyte coculture.

3 December 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Efficient induction of oligodendrocytes from human embryonic stem cells

3 December 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Motor neuron diversity in development and disease

3 December 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Human embryonic stem cell-derived motor neurons expressing SOD1 mutants exhibit typical signs of motor neuron degeneration linked to ALS.

3 December 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Directed differentiation of human-induced pluripotent stem cells generates active motor neurons

3 December 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury

3 December 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

The discovery of zinc fingers and their applications in gene regulation and genome manipulation.

3 December 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Can the pharmaceutical industry reduce attrition rates?

3 December 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Friedreich's ataxia induced pluripotent stem cells model intergenerational GAA⋅TTC triplet repeat instability

3 December 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Micropatterning neural cell cultures in 3D with a multi-layered scaffold

3 December 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

An efficient and reversible transposable system for gene delivery and lineage-specific differentiation in human embryonic stem cells

3 December 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Efficient transfection of embryonic and adult stem cells.

3 December 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture

3 December 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Human pluripotent stem cells in drug discovery and predictive toxicology

3 December 2024

82

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells.

3 December 2024

83

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells.

3 December 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons

3 December 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.

3 December 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Derivation of neural crest cells from human pluripotent stem cells

3 December 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Specification of motoneurons from human embryonic stem cells.

3 December 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2.

3 December 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

A chemical platform for improved induction of human iPSCs

3 December 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells

3 December 2024

91

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

A novel nuclear structure containing the survival of motor neurons protein

3 December 2024

92

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery

3 December 2024

94

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Spinal muscular atrophy: mechanisms and therapeutic strategies

3 December 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

3 December 2024

Spinal muscular atrophy.

97

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Rapid "open-source" engineering of customized zinc-finger nucleases for highly efficient gene modification

3 December 2024

98

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2.

3 December 2024

99

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Co-culture of neurons and glia in a novel microfluidic platform

3 December 2024

100

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells

3 December 2024

101

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders.

3 December 2024

103

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Derivation, culture, and characterization of VUB hESC lines

3 December 2024

104

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Identification and Classification of Chromosomal Aberrations in Human Induced Pluripotent Stem Cells

3 December 2024

105

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum.

3 December 2024

106

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease

3 December 2024

107

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy

3 December 2024

108

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development

3 December 2024

109

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Species differences in pharmacokinetics and drug teratogenesis

3 December 2024

111

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Loss-of-function of IKAP/ELP1: could neuronal migration defect underlie familial dysautonomia?

3 December 2024

112

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Rett syndrome: Revised diagnostic criteria and nomenclature

3 December 2024

113

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress

3 December 2024

114

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation

3 December 2024

115

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Progressive maturation in contracting cardiomyocytes derived from human embryonic stem cells: Qualitative effects on electrophysiological responses to drugs

3 December 2024

117

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Friedreich ataxia: the clinical picture

3 December 2024

118

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

The pathogenesis of Friedreich ataxia and the structure and function of frataxin

3 December 2024

119

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Microfluidic culture platform for neuroscience research

3 December 2024

120

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Retinoid-independent motor neurogenesis from human embryonic stem cells reveals a medial columnar ground state

3 December 2024

123

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Protein engineering: The fate of fingers

3 December 2024

124

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Programming embryonic stem cells to neuronal subtypes

3 December 2024

125

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Derivation of midbrain dopamine neurons from human embryonic stem cells

3 December 2024

126

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

BAC transgenesis in human embryonic stem cells as a novel tool to define the human neural lineage.

3 December 2024

127

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes.

3 December 2024

128

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Stem cells and drug discovery: the beginning of a new era?

3 December 2024

129

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Selection-free zinc-finger-nuclease engineering by context-dependent assembly (CoDA)

3 December 2024

130

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Differentiation of neural lineage cells from human pluripotent stem cells

3 December 2024

131

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells

3 December 2024

132

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Therapy development in spinal muscular atrophy

3 December 2024

133

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation

3 December 2024

134

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord injury.

3 December 2024

135

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Nucleofection of human embryonic stem cells.

3 December 2024

136

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia

3 December 2024

137

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Rescue of a human mRNA splicing defect by the plant cytokinin kinetin

3 December 2024

138

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Inhibition of Activin/Nodal signaling promotes specification of human embryonic stem cells into neuroectoderm

3 December 2024

139

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Hazard assessment of methylmercury toxicity to neuronal induction in embryogenesis using human embryonic stem cells

3 December 2024

141

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Generation of functional human hepatic endoderm from human induced pluripotent stem cells

3 December 2024

142

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Valproic acid increases SMN levels in spinal muscular atrophy patient cells.

3 December 2024

143

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

3 December 2024

144

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Micro-scale and microfluidic devices for neurobiology

3 December 2024

146

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Female human iPSCs retain an inactive X chromosome

3 December 2024

147

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice

3 December 2024

149

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Modeling for Lesch-Nyhan disease by gene targeting in human embryonic stem cells

3 December 2024

150

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells

3 December 2024

151

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

DNA triplexes and Friedreich ataxia

3 December 2024

153

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Predicting human developmental toxicity of pharmaceuticals using human embryonic stem cells and metabolomics

3 December 2024

154

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Directed differentiation of embryonic stem cells into motor neurons

3 December 2024

155

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Efficient and stable transgene expression in human embryonic stem cells using transposon-mediated gene transfer

3 December 2024

156

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Transgenes delivered by lentiviral vector are suppressed in human embryonic stem cells in a promoter-dependent manner

3 December 2024

157

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells.

3 December 2024

158

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Human iron-sulfur cluster assembly, cellular iron homeostasis, and disease

3 December 2024

159

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Pluripotent stem cell lines

3 December 2024

160

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Human embryonic stem cells as a model system for studying the effects of smoke exposure on the embryo

3 December 2024

163

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

In vitro differentiation of transplantable neural precursors from human embryonic stem cells

3 December 2024

164

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells

3 December 2024

165

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

High-Efficiency Induction of Neural Conversion in Human ESCs and Human Induced Pluripotent Stem Cells with a Single Chemical Inhibitor of Transforming Growth Factor Beta Superfamily Receptors

3 December 2024

166

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Reprogramming of human primary somatic cells by OCT4 and chemical compounds

3 December 2024

167

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells

3 December 2024

168

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

Homologous recombination in human embryonic stem cells.

3 December 2024

169

1 reference

https://api.crossref.org/works/10.1016/J.NEURON.2011.05.003

3 December 2024

Identifiers

1 reference

24 August 2017

1 reference